Maple The research peptide supply chain has undergone significant disruption in 2026. The shutdown of Peptide Sciences, previously the largest US-based supplier, has forced Canadian researchers to re-evaluate their sourcing strategy. This comparison examines the key differences between Canadian and US research peptide suppliers across testing standards, shipping logistics, and verification practices.
Shipping and Customs Considerations
Cross-border peptide orders from US suppliers introduce several variables that domestic Canadian orders eliminate entirely.
Transit Time
US-to-Canada peptide shipments typically require 5-14 business days including customs processing. According to Canada Border Services Agency data, approximately 12% of research compound shipments experience customs holds requiring additional documentation. These holds can extend delivery by an additional 3-7 business days.
Canadian domestic shipping eliminates customs entirely. Maple Research Labs offers same-day shipping from Vancouver, BC on orders placed before 2:00 PM PST, with typical delivery times of 1-3 business days to any Canadian address.
Temperature Control
Extended transit times increase the risk of temperature excursion. A 2020 study in the Journal of Pharmaceutical Sciences found that peptide degradation rates increase by approximately 2.5x for every 10 degrees Celsius above recommended storage temperature (n=18 peptide compounds tested across 72-hour exposure windows). Shorter domestic shipping windows reduce this risk substantially.
Currency and Cost
Orders from US suppliers are priced in USD. With the Canadian dollar historically trading between 0.72-0.78 USD over the past five years, a $100 USD order effectively costs $128-139 CAD before shipping, duties, or brokerage fees. Canadian suppliers price in CAD, eliminating exchange rate variability and hidden costs.
Testing and Verification Standards
Third-Party vs. In-House Testing
A 2023 analysis of 50 research peptide suppliers in North America found significant differences in testing practices:
- Only 14% of suppliers provided independently verifiable third-party COAs
- 62% used in-house testing with no independent verification available
- 24% provided no COA documentation at all
Among the 14% offering third-party testing, the most common independent laboratories were Janoshik Analytical (Prague), Colmaric Analyticals (US), and SGS (global). The key differentiator is not just whether testing is third-party, but whether the results are independently verifiable by the customer.
Verification Mechanisms
Janoshik Analytical, the laboratory used by Maple Research Labs, provides unique verification keys for each COA. These keys can be entered directly on the Janoshik website to confirm test results, creating a chain of verification that does not depend on the supplier’s claims.
This public verification mechanism is rare in the industry. Our complete testing documentation is available at the Certificates of Analysis page.
Regulatory Environment
Research peptides occupy a regulatory gray zone in both Canada and the United States. Neither country classifies most research peptides as controlled substances, but both impose restrictions on marketing them for human consumption.
In the US, the FDA’s updated enforcement posture in 2023-2024 has increased scrutiny on peptide suppliers, particularly those making therapeutic claims. Several US-based suppliers have faced enforcement actions, contributing to market instability. The shutdown of Peptide Sciences in April 2026 is the most significant market disruption to date.
For Canadian researchers, sourcing domestically from a Canadian supplier reduces exposure to US regulatory disruptions. A domestic supplier operating under Canadian law is not subject to FDA enforcement actions that can abruptly shut down US-based sources.
Supply Chain Reliability
The Peptide Sciences shutdown highlighted a critical risk in cross-border sourcing: supply chain dependency on a single foreign supplier. Researchers who had built their protocols around Peptide Sciences products were forced to find alternatives with minimal notice.
Canadian-based suppliers with domestic manufacturing and fulfillment provide insulation from:
- US regulatory enforcement actions
- Cross-border shipping disruptions
- Currency fluctuations
- Customs seizures or holds
- International supply chain delays
Comparison Summary
| Factor | US Supplier | Canadian Supplier (Maple Research Labs) |
|---|---|---|
| Shipping Time | 5-14 business days | 1-3 business days (same-day dispatch) |
| Customs Risk | 12% hold rate | None |
| Currency | USD (28-39% premium) | CAD |
| Third-Party COA | Varies | Every batch (Janoshik Analytical) |
| Public Verification | Rare | Verification keys on every COA |
| Regulatory Risk | FDA enforcement exposure | Canadian jurisdiction |
For Canadian researchers evaluating their supply chain after the Peptide Sciences disruption, the case for domestic sourcing is stronger than it has ever been. Browse the full catalog or review our COA verification documentation.
Disclaimer: All products are for research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.